iLite® Cell-based Complement Bioassays
Svar specializes in creating cell-based Reporter Gene Assays with iLite® technology for a range of complement applications. This technology offers a precise, sensitive system with luciferase readout, suitable for assessing drug activity for different targets such as C5a, and through Complement-Dependent Cytotoxicity (CDC) activity.
Our cell-based complement assays offer a new way of studying the complement system. Based on iLite® technology, these assays use a reporter gene system to detect the presence of the complement component for which they were designed. iLite assays offer excellent sensitivity and specificity which ensures that you get accurate results. As an added convenience, all iLite cell lines come assay-ready – no cell culturing is required. This results in a faster workflow and dramatically improved reproducibility and overall performance.